For help on how to get the results you want, see our search tips.
2 results
Medicine
Shortages Remove Shortages filter
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Referrals Remove Referrals filter
Referral authorisation model
Nationally authorised product(s) Remove Nationally authorised product(s) filter
Centrally authorised product(s) Remove Centrally authorised product(s) filter
Referral PRAC recommendation
Variation Remove Variation filter
Risk minimisation measures Remove Risk minimisation measures filter
No further action Remove No further action filter
Referral status
CMDh final position Remove CMDh final position filter
Referral decision making model
PRAC-CMDh Remove PRAC-CMDh filter
Referral safety status
Yes Remove Yes filter
-
List item
Referral: Cyproterone-containing medicinal products
cyproterone, Article 31 referrals
Status: CMDh final position, opinion/position date: 25/03/2020, Last updated: 20/05/2020 -
List item
Referral: Estradiol-containing (0.01% w/w) medicinal products for topical use
estradiol, associated names: Linoladiol, Linoladiol N, Linoladiol Estradiol, Estradiol Wolff, Montadiol, Article 31 referrals
Status: CMDh final position, opinion/position date: 30/01/2020, Last updated: 08/04/2020